Keisuke Hamada Selected Research

Carbamazepine (Tegretol)

2/2022

Amelioration of a neurodevelopmental disorder by carbamazepine in a case having a gain-of-function GRIA3 variant.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keisuke Hamada Research Topics

Disease

10	Neoplasms (Cancer) 04/2024 - 03/2002
8	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2023 - 01/2010
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 10/2017
2	Obesity 01/2023 - 05/2022
2	Epilepsy (Aura) 01/2023 - 06/2010
2	Muscular Dystrophies (Muscular Dystrophy) 08/2022 - 10/2021
2	Liver Diseases (Liver Disease) 02/2022 - 01/2022
2	Neurodevelopmental Disorders 02/2022 - 12/2018
1	Fibrosis (Cirrhosis) 04/2024
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024
1	Dermatitis 12/2023
1	Pelvic Neoplasms 06/2023
1	Intellectual Disability (Idiocy) 01/2023
1	Vision Disorders (Hemeralopia) 01/2023
1	Hemolysis 01/2023
1	Brain Diseases (Brain Disorder) 01/2023
1	Non-alcoholic Fatty Liver Disease 01/2023
1	Triple Negative Breast Neoplasms 10/2022
1	Breast Neoplasms (Breast Cancer) 10/2022
1	Metabolic Diseases (Metabolic Disease) 05/2022
1	Amyloidosis 05/2022
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 02/2022
1	Seizures (Absence Seizure) 02/2022
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021
1	Colitis 11/2021
1	Pierson syndrome 01/2021
1	Neuroblastoma 01/2021
1	Leukoencephalopathies 11/2011

Drug/Important Bio-Agent (IBA)

5	Nonsense Codon (Nonsense Mutation)IBA 01/2022 - 06/2015
4	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2010
4	DystrophinIBA 12/2023 - 01/2010
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 06/2015
3	negamycinIBA 12/2023 - 06/2015
3	Peptides (Polypeptides)IBA 10/2021 - 01/2021
2	FructoseIBA 04/2024 - 01/2023
2	CholesterolIBA 04/2024 - 01/2023
2	HydrazinesIBA 12/2023 - 06/2015
2	DipeptidesIBA 12/2023 - 01/2018
2	SpectrinIBA 08/2022 - 06/2010
2	Laminin (Merosin)IBA 08/2022 - 01/2021
2	EnzymesIBA 05/2022 - 02/2005
2	withaferin AIBA 02/2022 - 01/2022
1	LigandsIBA 04/2024
1	CCAAT-Enhancer-Binding ProteinsIBA 04/2024
1	Carbon Tetrachloride (Tetrachloromethane)IBA 04/2024
1	Messenger RNA (mRNA)IBA 04/2024
1	LuciferasesIBA 01/2023
1	GW 6471IBA 01/2023
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2023
1	Ion Channels (Ion Channel)IBA 01/2023
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2023
1	CationsIBA 01/2023
1	Fatty Acid-Binding ProteinsIBA 01/2023
1	Phosphotransferases (Kinase)IBA 11/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2022
1	Biomarkers (Surrogate Marker)IBA 10/2022
1	SpermineIBA 10/2022
1	N',N''-diacetylspermineIBA 10/2022
1	SpermidineIBA 10/2022
1	PolyaminesIBA 10/2022
1	SteroidsIBA 08/2022
1	Amyloid (Amyloid Fibrils)IBA 05/2022
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 05/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 05/2022
1	Immune Sera (Antisera)IBA 05/2022
1	Keratins (Keratin)IBA 05/2022
1	XenobioticsIBA 05/2022
1	Extracellular Matrix ProteinsIBA 05/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2022
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 05/2022
1	PPAR alphaIBA 05/2022
1	Keratin-5 (Keratin 5)IBA 05/2022
1	Glutamic Acid (Glutamate)FDA Link 02/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 02/2022
1	Therapeutic UsesIBA 02/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	Histones (Histone)IBA 11/2021
1	Dextrans (Dextran)FDA Link 11/2021
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 11/2021
1	Pregnane X ReceptorIBA 11/2021
1	Dystroglycans (Dystroglycan)IBA 10/2021
1	Liposomes (Liposome)IBA 10/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Amino Acids FDA Link 10/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2018
1	EstersIBA 10/2017
1	Epoxy Compounds (Epoxides)IBA 01/2016
1	FD 891IBA 01/2016
1	RNA Polymerase IIIIBA 11/2011
1	Lapatinib (GW572016)FDA Link 08/2010
1	Gefitinib (Iressa)FDA Link 08/2010
1	ErbB Receptors (EGF Receptor)IBA 08/2010

Therapy/Procedure

3	Therapeutics 04/2024 - 08/2022
3	Image-Guided Radiotherapy 06/2023 - 09/2020
2	Radiotherapy 12/2023 - 06/2023
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2023
1	Blood Transfusion (Blood Transfusions) 01/2023
1	Drug Therapy (Chemotherapy) 10/2022
1	Particle Accelerators 01/2022